Phenotype and genotype analysis in amyotrophic lateral sclerosis with TARDBP gene mutations

Objective: To describe the phenotype and phenotype–genotype correlations in patients with amyotrophic lateral sclerosis (ALS) with TARDBP gene mutations. Methods: French TARDBP+ patients with ALS (n = 28) were compared first to 3 cohorts: 737 sporadic ALS (SALS), 192 nonmutated familial ALS (FALS), and 58 SOD1 + FALS, and then to 117 TARDBP+ cases from the literature. Genotype–phenotype correlations were studied for the most frequent TARDBP mutations. Results: In TARDBP+ patients, onset was earlier (p = 0.0003), upper limb (UL) onset was predominant (p = 0.002), and duration was longer (p = 0.0001) than in patients with SALS. TARDBP+ and SOD1+ groups had the longest duration but diverged for site of onset: 64.3% UL onset for TARDBP+ and 74.1% on lower limbs for SOD1+ (p < 0.0001). The clinical characteristics of our 28 patients were similar to the 117 cases from the literature. In Caucasians, 51.3% of had UL onset, while 58.8% of Asians had bulbar onset (p = 0.02). The type of mutation influenced survival (p < 0.0001), and the G298S1, lying in the TARDBP super rich glycine-residue domain, was associated with the worst survival (27 months). Conclusion: Differences in phenotype between the groups as well as the differential influence of TARBDP mutations on survival may help physicians in ALS management and allow refining the strategy of genetic diagnosis.

[1]  A. Palamara,et al.  HSV-1 promotes Ca2+-mediated APP phosphorylation and Aβ accumulation in rat cortical neurons , 2011, Neurobiology of Aging.

[2]  Robert H. Brown,et al.  Mutational analysis of TARDBP in neurodegenerative diseases , 2011, Neurobiology of Aging.

[3]  David Heckerman,et al.  A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD , 2011, Neuron.

[4]  Janel O. Johnson,et al.  Large proportion of amyotrophic lateral sclerosis cases in Sardinia due to a single founder mutation of the TARDBP gene. , 2011, Archives of neurology.

[5]  Yi-Chung Lee,et al.  FUS, TARDBP, and SOD1 mutations in a Taiwanese cohort with familial ALS , 2011, Neurobiology of Aging.

[6]  Patrizia Sola,et al.  Exome Sequencing Reveals VCP Mutations as a Cause of Familial ALS , 2011, Neuron.

[7]  G. Tedeschi,et al.  TARDBP gene mutations in south Italian patients with amyotrophic lateral sclerosis , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[8]  O. Isacson,et al.  Global gene expression profiling of somatic motor neuron populations with different vulnerability identify molecules and pathways of degeneration and protection. , 2010, Brain : a journal of neurology.

[9]  V. Meininger,et al.  SOD1, ANG, VAPB, TARDBP, and FUS mutations in familial amyotrophic lateral sclerosis: genotype–phenotype correlations , 2010, Journal of Medical Genetics.

[10]  Takeo Kato,et al.  Mutations of optineurin in amyotrophic lateral sclerosis , 2010, Nature.

[11]  E. Bellone,et al.  Enlarging clinical spectrum of FALS with TARDBP gene mutations: S393L variant in an Italian family showing phenotypic variability and relevance for genetic counselling , 2010, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[12]  M. Itokawa,et al.  Familial ALS with G298S mutation in TARDBP: a comparison of CSF tau protein levels with those in sporadic ALS. , 2010, Internal medicine.

[13]  M. Itokawa,et al.  TDP-43 M337V mutation in familial amyotrophic lateral sclerosis in Japan. , 2010, Internal medicine.

[14]  J. Highley,et al.  Broad clinical phenotypes associated with TAR-DNA binding protein (TARDBP) mutations in amyotrophic lateral sclerosis , 2010, neurogenetics.

[15]  K. Williams,et al.  A novel TARDBP mutation in an Australian amyotrophic lateral sclerosis kindred , 2009, Journal of Neurology, Neurosurgery & Psychiatry.

[16]  M. Salmona,et al.  Proteomic profiling of cervical and lumbar spinal cord reveals potential protective mechanisms in the wobbler mouse, a model of motor neuron degeneration. , 2009, Journal of proteome research.

[17]  T. Miki,et al.  Screening for TARDBP mutations in Japanese familial amyotrophic lateral sclerosis , 2009, Journal of the Neurological Sciences.

[18]  N. Bresolin,et al.  TARDBP (TDP‐43) sequence analysis in patients with familial and sporadic ALS: identification of two novel mutations , 2009, European journal of neurology.

[19]  B. Dubois,et al.  TARDBP mutations in motoneuron disease with frontotemporal lobar degeneration , 2009, Annals of neurology.

[20]  B. Castellotti,et al.  High frequency of TARDBP gene mutations in Italian patients with amyotrophic lateral sclerosis , 2009, Human mutation.

[21]  Xun Hu,et al.  Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6 , 2009, Science.

[22]  A. Goris,et al.  TDP-43 M311V mutation in familial amyotrophic lateral sclerosis , 2009, Journal of Neurology, Neurosurgery, and Psychiatry.

[23]  V. Meininger,et al.  Contribution of TARDBP mutations to sporadic amyotrophic lateral sclerosis , 2008, Journal of Medical Genetics.

[24]  J. Trojanowski,et al.  Two German kindreds with familial amyotrophic lateral sclerosis due to TARDBP mutations. , 2008, Archives of neurology.

[25]  D. Geschwind,et al.  Novel Mutations in TARDBP (TDP-43) in Patients with Familial Amyotrophic Lateral Sclerosis , 2008, PLoS genetics.

[26]  B. McConkey,et al.  TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis , 2008, Nature Genetics.

[27]  Murray Grossman,et al.  TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis , 2008, The Lancet Neurology.

[28]  J. Morris,et al.  TDP‐43 A315T mutation in familial motor neuron disease , 2008, Annals of neurology.

[29]  A. Kakita,et al.  TDP‐43 mutation in familial amyotrophic lateral sclerosis , 2008, Annals of neurology.

[30]  Xun Hu,et al.  TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis , 2008, Science.

[31]  Avijit Chakrabartty,et al.  Structure, folding, and misfolding of Cu,Zn superoxide dismutase in amyotrophic lateral sclerosis. , 2006, Biochimica et biophysica acta.

[32]  W. Robberecht,et al.  The G93C mutation in superoxide dismutase 1: clinicopathologic phenotype and prognosis. , 2006, Archives of neurology.

[33]  P. Andersen.  Amyotrophic lateral sclerosis associated with mutations in the CuZn superoxide dismutase gene , 2006, Current neurology and neuroscience reports.

[34]  Orla Hardiman,et al.  “True” sporadic ALS associated with a novel SOD‐1 mutation , 2002, Annals of neurology.

[35]  M. Swash,et al.  El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis , 2000, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

[36]  V. Meininger,et al.  Genetics of familial ALS and consequences for diagnosis 1 , 1999, Journal of the Neurological Sciences.

[37]  H. Horvitz,et al.  Epidemiology of mutations in superoxide dismutase in amyotrophic lateal sclerosis , 1997, Annals of neurology.

[38]  P. Andersen,et al.  [Familial amyotrophic lateral sclerosis]. , 1996, Duodecim; laaketieteellinen aikakauskirja.

[39]  J. Haines,et al.  Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.